Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Webinar to be hosted on the future of pharma industry
The Future Career Conversations series, jointly organised by SRM Institute of Science & Technology and The Hindu, will host the sixth webinar in this series, ‘Pharma 2030: Innovation, Regulation and the Rise of India' on May 3 at 11.30 a.m.
Avalyn Pharma Upsized IPO Priced at Top of Expectations
Shares of Avalyn Pharma are set to make their trading debut Thursday after the clinical-stage biopharmaceutical company's upsized initial public offering was priced at the high end of expectations, raising $300 million. Avalyn late Wednesday said…
Watch Sun Pharma, Lilly Lead Latest Healthcare Deal Rush
Sun Pharma, Lilly Lead Latest Healthcare Deal Rush Bloomberg's Scarlet Fu on 'Bloomberg Deals' wraps up recent pharma dealmaking. Eli Lilly agreed to buy closely held Ajax Therapeutics for as much as $2.3 billion in cash. Sun Pharmaceutical…
Swiss pharma firm Novartis plans seventh US plant
The new plant will be dedicated to the production of active pharmaceutical ingredients for solid formulations (tablets, capsules) as well as for RNA-based therapies, the Basel-based pharmaceutical group said in a press release on Thursday. The…
Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management
Company announcement – No. 11 / 2026 Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management Phase 3 trials for chronic weight management planned for initiation in the second half…
Purdue Pharma Hit With Multibillion-Dollar Reckoning for Its Role in the Opioid Crisis
On Tuesday, OxyContin manufacturer Purdue Pharma was sentenced in federal court and subjected to criminal penalties. Yet another sign that nature, and the nation, are healing. Opioid manufacturer Purdue Pharma LP (Purdue) was sentenced today in…
LSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2025 RESULTS
BOUCHERVILLE, QC, April 30, 2026 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (the 'Corporation' or 'LSL Pharma '), a Canadian integrated pharmaceutical company, today reported its financial results for the fourth quarter and fiscal year ended…
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?
Dividend stocks may be a valuable element in your investing toolkit. This is because, no matter what the overall market is doing, they offer income that's pretty much guaranteed -- particularly if you choose a company with a long history of…
OxyContin Maker Purdue Pharma Set to Dissolve After Judge OKs Its Criminal Sentence
Oxycodone hydrochloride (OxyContin) maker Purdue Pharma is set to be dissolved and replaced by a company focused on the public good by the week's end, as a massive legal settlement resolving thousands of lawsuits takes effect. A federal judge on…
3 Boomerang-backed Pinnaql snaps up Pharma Resource Group
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Bain Capital sells nearly 1% stake in Emcure Pharma for ₹289 crore
Global investment firm Bain Capital has divested a nearly 1 per cent stake in Emcure Pharmaceuticals for over ₹289 crore through open market transactions, according to block deal data on the NSE. Following the stake sale, shares of Emcure…
NewAmsterdam Pharma (NAMS) Expected to Announce Earnings on Thursday
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) will likely be releasing its Q1 2026 results before the market opens on Thursday, May 7th. Analysts expect NewAmsterdam Pharma to post earnings of ($0.46) per share and revenue of $1.0930 million…
Indian Stock Markets Decline: Crude Oil, Global Trends, FII Outflows Impact Sentiment
Indian benchmark stock indices, Sensex and Nifty, experienced a nearly 1 per cent decline, influenced by soaring crude oil prices, adverse global market trends, and substantial foreign fund outflows, alongside escalating geopolitical tensions and…
Piramal Pharma expects FY 2027 to see a revival in growth
Piramal Pharma expects the current financial year (FY 2027) to see a revival in growth, even as geo-political uncertainties continue to cast a shadow on industry segments including pharmaceuticals. “FY27 will be a return to growth,”…
Jennison Associates LLC Trims Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
Jennison Associates LLC trimmed its holdings in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 16.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange…
Receive a Daily briefing on Pharma Industry News
Get Started